Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immunic | IMUX | Dec 30, 2024 | 1.03 | 0.00 |
ImmunityBio | IBRX | Dec 30, 2024 | 2.68 | -3.60 |
Immunocore ADR | IMCR | Dec 30, 2024 | 29.03 | -0.51 |
Immunome | IMNM | Dec 30, 2024 | 10.28 | -2.47 |
ImmunoPrecise Antibodies | IPA | Dec 30, 2024 | 0.41 | -0.24 |
Immunovant | IMVT | Dec 30, 2024 | 23.88 | -2.49 |
Immutep ADR | IMMP | Dec 30, 2024 | 2.08 | +3.48 |
Imperial Oil | IMO | Dec 30, 2024 | 61.13 | -1.67 |
Imperial Petroleum | IMPP | Dec 30, 2024 | 3.07 | +5.86 |
Imperial Petroleum A Pref | IMPPP | Dec 30, 2024 | 24.75 | +1.23 |
Impinj | PI | Dec 30, 2024 | 146.59 | -0.85 |
Imunon | IMNN | Dec 30, 2024 | 0.82 | +4.04 |
IN8bio | INAB | Dec 30, 2024 | 0.27 | -0.37 |
Inari Medical | NARI | Dec 30, 2024 | 51.93 | -1.96 |
Incannex Healthcare ADR | IXHL | Dec 30, 2024 | 2.09 | +7.18 |
Inception Growth Acquisition | IGTA | Dec 30, 2024 | 11.75 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Dec 30, 2024 | 12.00 | 0.00 |
Income Opportunity Realty Investors | IOR | Dec 30, 2024 | 17.82 | +0.08 |
Incyte | INCY | Dec 30, 2024 | 68.42 | -1.17 |
Indaptus Therapeutics | INDP | Dec 30, 2024 | 0.87 | +4.61 |
Independence Realty Trust | IRT | Dec 30, 2024 | 19.80 | -0.80 |
Independent Bank | IBCP | Dec 30, 2024 | 34.74 | +0.14 |
Independent Bank | INDB | Dec 30, 2024 | 64.11 | -1.37 |
Independent Bank Group | IBTX | Dec 30, 2024 | 60.39 | -0.26 |
India Bull 3X Direxion | INDL | Dec 30, 2024 | 59.56 | -1.85 |
India Consumer Egshares | INCO | Dec 30, 2024 | 64.28 | -0.72 |
India Earnings Wisdomtree | EPI | Dec 30, 2024 | 45.09 | -1.21 |
India Fund | IFN | Dec 30, 2024 | 15.71 | -1.26 |
India Powershares | PIN | Dec 30, 2024 | 25.76 | -1.00 |
Indie Semiconductor A | INDI | Dec 30, 2024 | 4.10 | -5.53 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.